Clinical Outsourcing Spend is Going Down

We recently posted that companies have been spending less and less money in clinical outsourcing as many companies are realizing that outsourcing does not necessarily make everything cheaper.

I have come across this post form PharmaTimes and another post from Outsourcing-Pharma and am wondering if this is a growing trend within pharma and biotech companies? I’m curious as to how this sudden change will this affect the future of contract research organizations.